| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |